SynopsisDaptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms. The global Daptomycin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, wi.....
SynopsisBenzatropine, also known as benztropine, is an anticholinergic marketed under the trade name Cogentin which is used in the treatment of Parkinson's disease, Parkinsonism, and dystonia. The global Benztropine Mesylate market was valued at US$ million in 2.....
SynopsisTildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoria.....
SynopsisSevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceutica.....
SynopsisPortable devices for treating stuttering or communication disorders include a circuit configured to automatically electronically select sua sponte different signal parameters and/or sound effect algorithms used to generate varied altered auditory feedback sign.....
SynopsisTeicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spe.....
SynopsisMedical waste incineration is the process of burning specific wastes, including pathological, trace chemotherapy and non-hazardous pharmaceutical wastes as it is considered the safest, most effective means of treatment and prevents harm to the environment and .....
SynopsisMRSA is the result of decades of often unnecessary antibiotic use. For years, antibiotics have been prescribed for colds, flu and other viral infections that don't respond to these drugs. The global MRSA Antibiotics market was valued at US$ 4055.6 millio.....
SynopsisRaltegravir (RAL), sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. The global Raltegravir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 20.....
SynopsisFamciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections. The global Famciclovir market was value.....
